AiNA

AiNA P(S)2 is a Swiss biotechnology company specializing in AI-driven drug discovery and drug repurposing through its proprietary Artificial Intelligence Network Analysis (AiNA) platform. The company utilizes advanced network biology and machine learning to identify novel therapeutic applications for existing compounds and to accelerate the discovery of new drug candidates. By mapping complex biological interactions and disease pathways, AiNA P(S)2 aims to reduce the time and cost associated with traditional drug development. The company collaborates with pharmaceutical partners and academic institutions to validate its computational findings and advance programs toward clinical development. Its primary focus areas include oncology, rare diseases, and infectious diseases, where high unmet medical needs exist.